Peroxisome proliferator-activated receptor-gamma activation reverses pulmonary arterial hypertension in an animal model, highlighting a potential therapeutic target linked to insulin resistance.
We have shown that insulin resistance, low plasma adiponectin levels, and deficiency of apoE may be risk factors for PAH and that peroxisome proliferator-activated receptor-gamma activation can reverse PAH in an animal model.
Hansmann et al. (Tue,) studied this question.